<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Granulocytic <z:hpo ids='HP_0100242'>sarcoma</z:hpo> (GS) is an uncommon and localized extramedullary <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> composed of immature granulocytic cells </plain></SENT>
<SENT sid="1" pm="."><plain>Most GS reported in large series were not associated with overt <z:hpo ids='HP_0004808'>acute myelogenous leukemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Gastric <z:mpath ids='MPATH_81'>perforation</z:mpath> occurred during <z:chebi fb="2" ids="8378">prednisolone</z:chebi> therapy in a 72-year-old Japanese male with a four-month history of a <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo>-like state </plain></SENT>
<SENT sid="3" pm="."><plain>Subtotal gastrectomy was performed for a suspected <z:hpo ids='HP_0002592'>gastric ulcer</z:hpo> <z:mpath ids='MPATH_81'>perforation</z:mpath> </plain></SENT>
<SENT sid="4" pm="."><plain>Gastric histologic, immunohistochemical and cytochemical examination revealed diffuse infiltration by sheets of myeloblasts and promyelocytes with scant or moderately abundant cytoplasm including a few eosinophilic myelocytes </plain></SENT>
<SENT sid="5" pm="."><plain>Bone marrow study done in one month after the operation disclosed <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess of blasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>) </plain></SENT>
<SENT sid="6" pm="."><plain>Leukemic transformation occurred two months later, and a subcutaneous <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> appeared on the forehead </plain></SENT>
<SENT sid="7" pm="."><plain>The forehead <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> predominantly consisted of myeloblasts without evidence of maturation </plain></SENT>
<SENT sid="8" pm="."><plain>Both the stomach and forehead <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> were examined immunohistochemically with a panel of monoclonal antibodies (LCA, L26, MT1, UCHL1, OPD4, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e>-1, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e>-2, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e>-3, MB1, Leu-M1, PM) and polyclonal antibodies (lysozyme, alpha 1-antitrypsin, alpha 1-antichymotrypsin, S-100 protein, lactoferrin), as well as <z:chebi fb="0" ids="35682">naphthol</z:chebi>-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ASD</z:e>-chloroacetate esterase staining to investigate and characterize the reliable marks for GS, and the patient was diagnosed as GS </plain></SENT>
<SENT sid="9" pm="."><plain>We found that gastric GS may occur in a <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo>-like state followed by <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> of <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> and that <z:chebi fb="0" ids="35682">naphthol</z:chebi>-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ASD</z:e>-chloroacetate esterase staining and immunohistochemical detection of MT1, lysozyme, and alpha 1-antitrypsin were the most reliable markers for confirming the diagnosis of GS </plain></SENT>
</text></document>